Insight Inv LLC Has $868,000 Stock Position in CVS Health Corporation $CVS

Insight Inv LLC decreased its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,578 shares of the pharmacy operator’s stock after selling 528 shares during the period. Insight Inv LLC’s holdings in CVS Health were worth $868,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CVS. Miracle Mile Advisors LLC raised its holdings in CVS Health by 17.3% during the 1st quarter. Miracle Mile Advisors LLC now owns 10,474 shares of the pharmacy operator’s stock worth $710,000 after purchasing an additional 1,543 shares during the last quarter. Park Avenue Securities LLC raised its holdings in CVS Health by 5.0% during the 1st quarter. Park Avenue Securities LLC now owns 25,890 shares of the pharmacy operator’s stock worth $1,754,000 after purchasing an additional 1,244 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in CVS Health by 27.2% during the 1st quarter. Farther Finance Advisors LLC now owns 16,278 shares of the pharmacy operator’s stock worth $1,107,000 after purchasing an additional 3,481 shares during the last quarter. GAMMA Investing LLC raised its holdings in CVS Health by 198.5% during the 1st quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator’s stock worth $1,265,000 after purchasing an additional 12,415 shares during the last quarter. Finally, Sonora Investment Management Group LLC raised its holdings in CVS Health by 36.9% during the 1st quarter. Sonora Investment Management Group LLC now owns 7,234 shares of the pharmacy operator’s stock worth $490,000 after purchasing an additional 1,950 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Insider Activity

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.22% of the company’s stock.

CVS Health Price Performance

Shares of CVS opened at $76.94 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The stock has a 50 day simple moving average of $71.68 and a 200 day simple moving average of $67.52. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $79.20. The firm has a market capitalization of $97.59 billion, a PE ratio of 21.49, a P/E/G ratio of 0.85 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same period in the previous year, the firm earned $1.83 EPS. CVS Health’s quarterly revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s payout ratio is currently 74.30%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CVS. Wells Fargo & Company boosted their price objective on CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a report on Tuesday. Cowen reaffirmed a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Zacks Research cut CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $78.00 price target on shares of CVS Health in a research note on Tuesday, August 26th. Finally, Robert W. Baird raised CVS Health from a “neutral” rating to an “outperform” rating and upped their price target for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $79.20.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.